HAEMATO AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
173,566.20
202,674.40
229,727.30
275,613.70
289,862.20
274,100
Cost of Goods Sold (COGS) incl. D&A
167,198.50
192,932.90
221,615.00
263,955.30
277,975.20
260,773.90
Gross Income
6,367.70
9,741.50
8,112.30
11,658.40
11,887.10
13,346.70
SG&A Expense
4,836.70
6,008.90
6,461.90
8,420.20
8,947.90
8,520.30
EBIT
1,515.60
3,731.50
1,647.30
3,222.90
3,570.20
6,011.40
Unusual Expense
2,174.00
-
4,429.20
9,657.00
5,031.00
1,943
Non Operating Income/Expense
6,228.90
4,500.90
1,578.70
546.30
1,442.10
865.70
Interest Expense
1,370.70
1,551.10
1,640.40
1,858.20
1,960.00
1,075.10
Pretax Income
8,991.20
6,866.30
6,025.40
12,243.90
8,085.70
7,761.10
Income Tax
611.20
112.10
485.80
1,207.20
1,102.90
1,484.70
Consolidated Net Income
8,380.00
6,978.50
5,539.60
11,036.70
6,982.70
6,276.50
Net Income
7,940.10
6,978.50
5,539.60
11,036.70
6,982.70
6,276.50
Net Income After Extraordinaries
7,940.10
6,978.50
5,539.60
11,036.70
6,982.70
6,276.50
Net Income Available to Common
7,940.10
6,978.50
5,539.60
11,036.70
6,982.70
6,276.50
EPS (Basic)
0.41
0.34
0.27
0.53
0.33
0.28
Basic Shares Outstanding
19,583.80
20,778.90
20,778.90
20,778.90
21,466.70
22,419.90
EPS (Diluted)
0.41
0.34
0.27
0.53
0.33
0.28
Diluted Shares Outstanding
19,583.80
20,778.90
20,778.90
20,778.90
21,466.70
22,419.90
EBITDA
3,328.80
5,787.40
3,447.10
5,028.20
5,424.60
7,467.50
Other Operating Expense
15.50
1.00
3.10
15.20
631.00
1,185
Non-Operating Interest Income
443.40
184.90
10.60
675.90
2.40
16.20
Minority Interest Expense
439.90
-
-
-
-
-

About HAEMATO

View Profile
Address
Lilienthalstraße 5c
Schönefeld Brandenburg 12529
Germany
Employees -
Website http://haemato.de
Updated 07/08/2019
Haemato AG engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes therapies for cancer, HIV, rheumatology, and other chronic diseases. It also consists of products for the privately financed market for aesthetic treatments.